KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Shares Outstanding (2016 - 2025)

Novavax has reported Shares Outstanding over the past 16 years, most recently at $162.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $162.6 million for Q4 2025, up 1.34% from a year ago — trailing twelve months through Dec 2025 was $162.6 million (up 1.34% YoY), and the annual figure for FY2025 was $162.6 million, up 1.34%.
  • Shares Outstanding for Q4 2025 was $165.0 million at Novavax, up from $162.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for NVAX hit a ceiling of $165.0 million in Q4 2025 and a floor of $74.5 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $107.4 million (2023), compared with a mean of $117.4 million.
  • Biggest five-year swings in Shares Outstanding: soared 226757.31% in 2021 and later grew 0.56% in 2025.
  • Novavax's Shares Outstanding stood at $76.4 million in 2021, then grew by 13.57% to $86.8 million in 2022, then soared by 61.86% to $140.5 million in 2023, then increased by 14.17% to $160.4 million in 2024, then increased by 1.34% to $162.6 million in 2025.
  • The last three reported values for Shares Outstanding were $162.6 million (Q4 2025), $162.5 million (Q3 2025), and $164.5 million (Q2 2025) per Business Quant data.